Trademark: 79323815
Word
SEEGENE
Status
Registered
Status Code
700
Status Date
Tuesday, January 31, 2023
Serial Number
79323815
Registration Number
6966080
Registration Date
Tuesday, January 31, 2023
Mark Type
4000
Filing Date
Tuesday, July 6, 2021
Published for Opposition
Tuesday, November 15, 2022

Trademark Owner History
SEEGENE, INC. - Original Registrant

Classifications
44 Pharmaceutical advice; pharmacy advice in the field of preparation of prescriptions in pharmacies; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products via the Internet; telemedicine services; medical services; medical information services provided via the Internet; medical and pharmaceutical consultation; medical testing services, namely, medical diagnostic testing; medical testing for diagnostic or treatment purposes; medical cancer testing for diagnostic or treatment purposes; genetic testing for medical purposes; healthcare services through the Internet; consulting services in the field of health management in the nature of managing health conditions through the internet; medical clinical pathology examination; health checkup and information services related thereto; medical clinical test in the nature of diagnostic testing and genetic testing for treatment purposes and information services related thereto; providing collected and managed medical information and personal health information; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation to improve health culture; healthcare; health counselling; physical examination services; hospital services, not including dentistry services; medical clinic services, not including dentistry services; telemedicine services, not including dentistry services; rental of medical and health care equipment; medical assistance services; medical consultation services, not including dentistry services; medical equipment rental; providing health information services, not including dentistry services; health center services; performing diagnosis of diseases; medical and diagnostic services, namely, identifying hereditary risk factors; medical and medical diagnostic services for disease prevention; medical and diagnostic services, namely, diagnosing in the nature of in vitro diagnostic services for medical purposes; medical analysis services relating to the treatment of persons, namely, analysis of human bodily fluid and tissue samples for diagnostic and treatment services provided by a medical laboratory
42 Research and development in the field of special testing using genetic engineering; biological services, namely, testing and analysis of biological samples in research laboratories; research and development of DNA chips; structural and functional analysis of genomes; biotechnological research; advisory services relating to biotechnological research; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; chemical analysis; research in the field of chemistry; chemical research and analysis; chemical research; research and development of vaccines and medicines; crude drugs research; research on adult diseases; bacteriological research; scientific research for medical purposes in the field of cancerous diseases; research relating to medicines; pharmaceutical products evaluation; consultancy pertaining to pharmacology; testing of pharmaceuticals; pharmaceutical research; medical research; medical science research in the field of clinical pathology and special examination; scientific research in the nature of conducting clinical trials for others; medical research and technical diagnostic testing services for evaluating clinical trial progress; medical research laboratory services for predicting disease; medical laboratory services, namely, preparation and analysis of human body tissue and fluid samples, providing reports respecting the same; research and development of infectious disease diagnosis products; research and development agency of infectious disease diagnosis products; research and development of bacterial and virus test products; research and development agency of bacterial and virus test products; research and development of genetic disease diagnosis products; research and development agency of genetic disease diagnosis products; research and development of blood analysis; research and development agency of blood analysis; research and development agency of cell test products for medical research, treatment, and diagnosis; research and development of cell test products for medical research, treatment, and diagnosis; research and development of body fluid and tissue sample analysis products for medical research, treatment, and diagnosis; research and development agency of body fluid and tissue sample analysis products for medical research, treatment, and diagnosis

Trademark Events
May 30, 2023
Final Decision Transaction Processed By Ib
May 4, 2023
Final Disposition Notice Sent To Ib
May 4, 2023
Final Disposition Processed
Apr 30, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jan 31, 2023
Notice Of Registration Confirmation Emailed
Jan 31, 2023
Registered-Principal Register
Nov 15, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 15, 2022
Published For Opposition
Oct 26, 2022
Notification Of Notice Of Publication E-Mailed
Oct 10, 2022
Approved For Pub - Principal Register
Oct 10, 2022
Examiner's Amendment Entered
Oct 10, 2022
Notification Of Examiners Amendment E-Mailed
Oct 10, 2022
Examiners Amendment E-Mailed
Oct 10, 2022
Examiners Amendment -Written
Sep 10, 2022
Teas/Email Correspondence Entered
Sep 9, 2022
Correspondence Received In Law Office
Sep 9, 2022
Teas Response To Office Action Received
Jun 6, 2022
Refusal Processed By Ib
May 16, 2022
Non-Final Action Mailed - Refusal Sent To Ib
May 16, 2022
Refusal Processed By Mpu
Apr 1, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Mar 31, 2022
Non-Final Action Written
Mar 25, 2022
Assigned To Examiner
Oct 30, 2021
Application Filing Receipt Mailed
Oct 26, 2021
New Application Office Supplied Data Entered
Oct 22, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24